Voronoi310210
Voronoi (310210) Amended Material Information, Nov 10, 2026
Filing date ·
Voronoi corrected the target number of subjects for its VRN110755 Phase 1/2 clinical trial from about 255 to about 355.
Sign in to read this filing in detail
Continue to the filing details and any available analysis after signing in.
Filing lists and official source links are available without signing in.